 |
Top 10 Gastroenterology startups
Updated: May 01, 2024 | Editor: Jason Kwon |
Gastroenterology startups are developing solutions such as AI-powered diagnostic algorithms, smart pill technology for targeted drug delivery, and telemedicine platforms for remote consultations, enabling more accurate diagnoses, personalized treatment plans, and improved patient outcomes.
1
Country: USA | Funding: $1B
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
2
Country: USA | Funding: $537.8M
Seres Therapeutics is creating a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis
Seres Therapeutics is creating a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis
3
Country: USA | Funding: $407.2M
Synergy is a gastrointestinal-focused biopharmaceutical company committed to science-based innovation, providing novel treatment options for patients and healthcare providers, rewarding opportunities for our employees, and creating exceptional value for our shareholders.
Synergy is a gastrointestinal-focused biopharmaceutical company committed to science-based innovation, providing novel treatment options for patients and healthcare providers, rewarding opportunities for our employees, and creating exceptional value for our shareholders.
4
Country: USA | Funding: $341.6M
Ventyx Biosciences develops a drug for inflammatory bowel disease
Ventyx Biosciences develops a drug for inflammatory bowel disease
5
Country: USA | Funding: $173M
Metacrine is an emerging biotech company focused on developing best-in-class therapies to benefit patients with liver, gastrointestinal, and metabolic diseases.
Metacrine is an emerging biotech company focused on developing best-in-class therapies to benefit patients with liver, gastrointestinal, and metabolic diseases.
6
Country: USA | Funding: $150.4M
Allurion Technologies develops a medical device for weight loss that can be delivered and removed without surgery or endoscopy.
Allurion Technologies develops a medical device for weight loss that can be delivered and removed without surgery or endoscopy.
7
Country: USA | Funding: $95.6M
CapsoVision is a medical device company developing gastrointestinal medical devices.
CapsoVision is a medical device company developing gastrointestinal medical devices.
8
Country: USA | Funding: $60M
Oshi Health is a virtual-first medical practice revolutionizing the diagnosis, management and treatment of digestive health conditions.
Oshi Health is a virtual-first medical practice revolutionizing the diagnosis, management and treatment of digestive health conditions.
9
Country: USA | Funding: $58.8M
Vivante makes a digital program for digestive health and disease called GIThrive that includes, among other tools, a 24-7 support line to a gastrointestinal care team.
Vivante makes a digital program for digestive health and disease called GIThrive that includes, among other tools, a 24-7 support line to a gastrointestinal care team.
10
Country: Italy | Funding: €39M
Enthera's mission is to find new therapeutic approaches to treat diabetes and related gastrointestinal complication (enteropathy), as well as other intestinal disorders sharing the same biological pathway.
Enthera's mission is to find new therapeutic approaches to treat diabetes and related gastrointestinal complication (enteropathy), as well as other intestinal disorders sharing the same biological pathway.
11
Country: Canada | Funding: $35.2M
Medical Device startup developing a solution to detect gastrointestinal leaks after surgical procedures.
Medical Device startup developing a solution to detect gastrointestinal leaks after surgical procedures.
12
Country: USA | Funding: $25.7M
Ritter Pharmaceuticals, Inc. develops novel therapeutic products, which modulate the human gut microbiome to treat inflammatory, gastrointestinal and metabolic diseases. We are discovering a new frontier in human gut health research by exploring the metabolic capacity of the gut microbiota and translating the functionality of prebiotic-based therapeutics into safe and effective applications that can have a meaningful impact on a patient’s health.
Ritter Pharmaceuticals, Inc. develops novel therapeutic products, which modulate the human gut microbiome to treat inflammatory, gastrointestinal and metabolic diseases. We are discovering a new frontier in human gut health research by exploring the metabolic capacity of the gut microbiota and translating the functionality of prebiotic-based therapeutics into safe and effective applications that can have a meaningful impact on a patient’s health.
13
Country: Israel | Funding: $19M
Envizion Medical develops electromagnetic feeding tube placement devices.
Envizion Medical develops electromagnetic feeding tube placement devices.
14
Country: Germany | Funding: $16M
Cara Care empowers patients suffering from chronic digestive diseases to live a healthier and happier life.
Cara Care empowers patients suffering from chronic digestive diseases to live a healthier and happier life.
15
Country: Israel | Funding: $15M
Vibrant has developed the first non-drug treatment for chronic constipation via mechanical stimulation of the gut, that helps patients obtain relief and live better with their condition. The treatment empowers physicians with digital tools to provide optimized and better care.
Vibrant has developed the first non-drug treatment for chronic constipation via mechanical stimulation of the gut, that helps patients obtain relief and live better with their condition. The treatment empowers physicians with digital tools to provide optimized and better care.
16
Country: Israel | Funding: $15M
Vibrant is a developer and producer of chemical-free capsule for constipation treatment.
Vibrant is a developer and producer of chemical-free capsule for constipation treatment.
17
Country: Singapore | Funding: $10.5M
Asian Microbiome Library microbiome company and a stool bank serving as a hub for gut microbiome therapy.
Asian Microbiome Library microbiome company and a stool bank serving as a hub for gut microbiome therapy.
18
Country: USA | Funding: $10.5M
Salvo Health offers a virtual clinic geared toward people with chronic gut problems, including irritable bowel syndrome (IBS), celiac disease, gastroesophageal reflux disease (GERD), dyspepsia and small intestinal bacterial overgrowth (SIBO).
Salvo Health offers a virtual clinic geared toward people with chronic gut problems, including irritable bowel syndrome (IBS), celiac disease, gastroesophageal reflux disease (GERD), dyspepsia and small intestinal bacterial overgrowth (SIBO).
19
Country: France | Funding: $10.3M
SAS TargEDys develops mechanisms involving hormone mimetic proteins linked to microbiota for the treatment of eating disorders such as hyperphagia or anorexia.
SAS TargEDys develops mechanisms involving hormone mimetic proteins linked to microbiota for the treatment of eating disorders such as hyperphagia or anorexia.
20
Country: Australia | Funding: $10M
Endogene has developed a self-advancing single-use gastrointestinal endoscope platform. Provides safe, timely, relaible and cost-effective access to entire GI tract. Advanced 4k imaging and AI-assisted diagnose.
Endogene has developed a self-advancing single-use gastrointestinal endoscope platform. Provides safe, timely, relaible and cost-effective access to entire GI tract. Advanced 4k imaging and AI-assisted diagnose.
21
Country: USA | Funding: $8.3M
DNAlite Therapeutics committed to bringing the next-generation of drugs to organs protected by mucus barriers. Diseases such as FAP, colorectal cancer, and Crohn's disease are currently treated with complete or partial removal of the colon and/or rectum. Our aim is to prevent, rather than manage the progression of these diseases.
DNAlite Therapeutics committed to bringing the next-generation of drugs to organs protected by mucus barriers. Diseases such as FAP, colorectal cancer, and Crohn's disease are currently treated with complete or partial removal of the colon and/or rectum. Our aim is to prevent, rather than manage the progression of these diseases.
22
Country: USA | Funding: $6.3M
MetaMe Health is committed to developing FDA-approved prescription digital therapeutics for the treatment of gastrointestinal conditions.
MetaMe Health is committed to developing FDA-approved prescription digital therapeutics for the treatment of gastrointestinal conditions.
23
Country: Ireland | Funding: $4M
EnteraSense is developing an ingestible biosensor that detects bleeding in the gastrointestinal tract in real time without requiring a complicated intervention.
EnteraSense is developing an ingestible biosensor that detects bleeding in the gastrointestinal tract in real time without requiring a complicated intervention.
24
Country: USA | Funding: $2.2M
SmartTab is a digital medicine company which develops innovative wireless drug delivery and monitoring systems.
SmartTab is a digital medicine company which develops innovative wireless drug delivery and monitoring systems.
25
Country: USA | Funding: $1.5M
Kiwi Bio aims to free irritable bowel syndrome sufferers from restrictive diets. Kiwi’s product FODZYME uses patent-pending enzymes to break down common digestive triggers.
Kiwi Bio aims to free irritable bowel syndrome sufferers from restrictive diets. Kiwi’s product FODZYME uses patent-pending enzymes to break down common digestive triggers.
26
Country: Israel | Funding: $100K
Exosomm develops food solutions based on natural milk exosomes. Exosomm’s first product is a food formula with a patented-based active anti-inflammatory effect designed for patients with inflammatory bowel diseases (Crohn´s & Colitis).
Exosomm develops food solutions based on natural milk exosomes. Exosomm’s first product is a food formula with a patented-based active anti-inflammatory effect designed for patients with inflammatory bowel diseases (Crohn´s & Colitis).
27
Country: USA
Casa de Sante is transforming gut health through convenient, personalized and virtual therapeutic care.
Casa de Sante is transforming gut health through convenient, personalized and virtual therapeutic care.
